Advertisement

Response to “Letter to the editor of radiotherapy and oncology regarding of the article “Dosimetric parameters related to occurrence of distant metastases and regional nodal relapse after SBRT for early-stage non-small cell lung cancer” by Lalonde et al.”

      We thank the authors of this letter [
      • Yang K.
      • Sun C.
      • Yin R.
      Letter to the editor of radiotherapy and oncology regarding of the article “Dosimetric parameters related to occurrence of distant metastases and regional nodal relapse after SBRT for early-stage non-small cell lung cancer” by Lalonde et al.
      ] for their interest in our work [
      • Lalonde R.
      • Abdelhakiem M.
      • Keller A.
      • Huq M.S.
      Dosimetric parameters related to occurrence of distant metastases and regional nodal relapse after SBRT for early-stage non-small cell lung cancer.
      ]. They discuss several concerns about the work, which we will be happy to address.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Radiotherapy and Oncology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Yang K.
        • Sun C.
        • Yin R.
        Letter to the editor of radiotherapy and oncology regarding of the article “Dosimetric parameters related to occurrence of distant metastases and regional nodal relapse after SBRT for early-stage non-small cell lung cancer” by Lalonde et al.
        Radiother Oncol. 2022;
        • Lalonde R.
        • Abdelhakiem M.
        • Keller A.
        • Huq M.S.
        Dosimetric parameters related to occurrence of distant metastases and regional nodal relapse after SBRT for early-stage non-small cell lung cancer.
        Radiother Oncol. 2022; 169: 90-95
        • Diamant A.
        • Chatterjee A.
        • Faria S.
        • Naqa I.E.
        • Bahig H.
        • Filion E.
        • et al.
        Can dose outside the PTV influence the risk of distant metastases in stage I lung cancerpatients treated with stereotactic body radiotherapy.
        Radiother Oncol. 2018; 128: 513-519https://doi.org/10.1016/j.radonc.2018.05.012
        • Diamant A.
        • Heng V.J.
        • Chatterjee A.
        • Faria S.
        • Bahig H.
        • Filion E.
        • et al.
        Comparing local control and distant metastasis in NSCLC patients between CyberKnife and conventional SBRT.
        Radiother Oncol. 2020; 144: 201-208

      Linked Article